Belgium-Based Complix NV Raises Eur 5 Million
PeHub -- Complix NV, a Belgium-based developer of “alphabodies” for autoimmune and infectious diseases, has raised €5 million in Series A funding. Backers include Vesalius Biocapital, LRM and CRP Santé.